Vigilant Capital Management’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-121	Closed	-$12K	–	715
2021 Q3	$12K	Buy	+121	New	+$12K	﹤0.01%	462